AURKA
Aurora kinase A
Also known as: AIK, ARK1, AurA, AURKA_HUMAN, BTAK, PPP1R47, STK15, STK6, STK7
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O14965
- Gene
- AURKA
- Ensembl
- ENSG00000087586
- Chromosome
- 20
- Canonical length
- 403 aa
- Protein class
- Cancer-related genes, Enzymes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Mitotic spindle,Centrosome,Basal body,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a cell cycle-regulated kinase that appears to be involved in microtubule formation and/or stabilization at the spindle pole during chromosome segregation. The encoded protein is found at the centrosome in interphase cells and at the spindle poles in mitosis. This gene may play a role in tumor development and progression. A processed pseudogene of this gene has been found on chromosome 1, and an unprocessed pseudogene has been found on chromosome 10. Multiple transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
403 residues, UniProt reviewed canonical sequence.
>O14965|AURKA
1 MDRSKENCIS GPVKATAPVG GPKRVLVTQQ FPCQNPLPVN SGQAQRVLCP SNSSQRIPLQ
61 AQKLVSSHKP VQNQKQKQLQ ATSVPHPVSR PLNNTQKSKQ PLPSAPENNP EEELASKQKN
121 EESKKRQWAL EDFEIGRPLG KGKFGNVYLA REKQSKFILA LKVLFKAQLE KAGVEHQLRR
181 EVEIQSHLRH PNILRLYGYF HDATRVYLIL EYAPLGTVYR ELQKLSKFDE QRTATYITEL
241 ANALSYCHSK RVIHRDIKPE NLLLGSAGEL KIADFGWSVH APSSRRTTLC GTLDYLPPEM
301 IEGRMHDEKV DLWSLGVLCY EFLVGKPPFE ANTYQETYKR ISRVEFTFPD FVTEGARDLI
361 SRLLKHNPSQ RPMLREVLEH PWITANSSKP SNCQNKESAS KQSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AURKA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 29 nTPM
Expression across tissuesHPA
Tissue
- testis: 29 nTPM
- tonsil: 21 nTPM
- lymph node: 20 nTPM
- thymus: 19 nTPM
- bone marrow: 15 nTPM
- rectum: 12 nTPM
Single-cell type
- oocytes: 355 nCPM
- late primary spermatocytes: 269 nCPM
- monocyte progenitors: 90 nCPM
- extravillous trophoblasts: 77 nCPM
- erythrocyte progenitors: 62 nCPM
- migrating cytotrophoblasts: 57 nCPM
Immune cell
- intermediate monocyte: 5.9 nTPM
- T-reg: 4.8 nTPM
- eosinophil: 4.3 nTPM
- myeloid DC: 3.7 nTPM
- classical monocyte: 3.5 nTPM
- non-classical monocyte: 3.4 nTPM
Brain region
- cerebellum: 7.7 nTPM
- medulla oblongata: 6.6 nTPM
- cerebral cortex: 6.4 nTPM
- thalamus: 6.4 nTPM
- basal ganglia: 6.2 nTPM
- pons: 5.8 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about AURKA.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 51 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Disease | ImmuneIEDB
Conditions an epitope on AURKA was assayed in.
- urinary bladder cancer T cell
- lung cancer T cell
- acute myeloid leukemia T cell
- invasive ductal carcinoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.39
- gnomAD pLI
- 0.87
- gnomAD missense Z
- 1.6
- DepMap mean gene effect
- -1.24
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 12% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anterior/posterior axis specification
- apoptotic process
- cell division
- centrosome localization
- cilium disassembly
- G2/M transition of mitotic cell cycle
- liver regeneration
- mitotic cell cycle
- mitotic centrosome separation
- mitotic spindle organization
- negative regulation of apoptotic process
- negative regulation of gene expression
- negative regulation of protein binding
- neuron projection extension
- peptidyl-serine phosphorylation
- positive regulation of mitochondrial fission
- positive regulation of mitotic cell cycle
- positive regulation of mitotic nuclear division
- positive regulation of oocyte maturation
- positive regulation of proteasomal ubiquitin-dependent protein catabolic process
- proteasome-mediated ubiquitin-dependent protein catabolic process
- protein autophosphorylation
- protein localization to centrosome
- protein phosphorylation
- regulation of centrosome cycle
- regulation of cytokinesis
- regulation of G2/M transition of mitotic cell cycle
- regulation of protein stability
- regulation of signal transduction by p53 class mediator
- response to wounding
- spindle assembly involved in female meiosis I
- spindle organization
Molecular functions
- ATP binding
- histone H3S10 kinase activity
- molecular function activator activity
- protein heterodimerization activity
- protein kinase activity
- protein kinase binding
- protein serine kinase activity
- protein serine/threonine kinase activity
- protein serine/threonine/tyrosine kinase activity
- ubiquitin protein ligase binding
Cellular components
- axon hillock
- basolateral plasma membrane
- centriole
- centrosome
- chromosome passenger complex
- ciliary basal body
- cytosol
- germinal vesicle
- glutamatergic synapse
- kinetochore
- meiotic spindle
- microtubule
- microtubule cytoskeleton
- midbody
- mitotic spindle
- mitotic spindle pole
- nucleoplasm
- nucleus
- perinuclear region of cytoplasm
- postsynaptic density
- pronucleus
- spindle
- spindle midzone
- spindle pole
- spindle pole centrosome
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AURKA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AURKA as an antibody target. Whether an autoantibody or antibody against AURKA could matter depends on whether native AURKA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AURKA is annotated at the cell surface, where native AURKA is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label AURKA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...